The impact of HIV antiviral therapy on human papillomavirus (HPV) infections and HPV-related diseases.
about
The viral etiology of AIDS-associated malignanciesThe distribution of sexually-transmitted Human Papillomaviruses in HIV positive and negative patients in Zambia, Africa.Human papillomavirus prevalence, viral load and pre-cancerous lesions of the cervix in women initiating highly active antiretroviral therapy in South Africa: a cross-sectional study.Prevalence and predictors of colposcopic-histopathologically confirmed cervical intraepithelial neoplasia in HIV-infected women in India.Giant Condyloma Acuminatum of Vulva in an HIV-Infected WomanRelationship of immunologic response to antiretroviral therapy with non-AIDS defining cancer incidence.Double jeopardy: HIV and cervical cancer in Indian womenCervical cancer precursors and hormonal contraceptive use in HIV-positive women: application of a causal model and semi-parametric estimation methods.Human papillomavirus-related disease in men: not just a women's issueOncogenic viruses associated with vulva cancer in HIV-1 patients in Botswana.Pattern of cancer risk in persons with AIDS in Italy in the HAART era.The impact of HAART on HPV-related cervical disease.Local tumor control and toxicity in HIV-associated anal carcinoma treated with radiotherapy in the era of antiretroviral therapy.Aging-associated changes in hematopoiesis and leukemogenesis: what's the connection?HPV Infection in a Cohort of HIV-Positive Men and Women: Prevalence of Oncogenic Genotypes and Predictors of Mucosal Damage at Genital and Oral Sites.Prevalence and Risk Factors Associated with Precancerous Cervical Cancer Lesions among HIV-Infected Women in Resource-Limited Settings.The agmatine-containing poly(amidoamine) polymer AGMA1 binds cell surface heparan sulfates and prevents attachment of mucosal human papillomavirusesAssociation of HIV viral load and CD4 cell count with human papillomavirus detection and clearance in HIV-infected women initiating highly active antiretroviral therapy.Risk of human papillomavirus-associated cancers among persons with AIDS.Management of cryotherapy-ineligible women in a "screen-and-treat" cervical cancer prevention program targeting HIV-infected women in Zambia: lessons from the field.Implementation of 'see-and-treat' cervical cancer prevention services linked to HIV care in Zambia.Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia.The burden, distribution and risk factors for cervical oncogenic human papilloma virus infection in HIV positive Nigerian women.Associations between highly active antiretroviral therapy and the presence of HPV, premalignant and malignant cervical lesions in sub-Saharan Africa, a systematic review: current evidence and directions for future research.Atypical perianal herpes simplex infection in HIV-positive patients.Mouse papillomavirus infection persists in mucosal tissues of an immunocompetent mouse strain and progresses to cancer.High prevalence of cervical squamous intraepithelial lesions in women on antiretroviral therapy in Cameroon: Is targeted screening feasible?
P2860
Q24685892-20683BE4-F042-47DE-829B-AF7B704E57F5Q33290996-6326236C-D9AB-45E1-BC76-3738F1EE58FFQ33491795-EBC2EA46-8EAB-4A55-A890-884651B8BD6BQ33523800-0FEF5D8E-99DC-4B0C-A616-015E4016EA43Q33608047-7617BC0E-5FFD-4A7D-A9BF-ACB780A8123DQ33696149-033C1B30-C796-4E95-8D24-A18D52830C0AQ33725006-392AA15D-8ACA-4830-8743-4AB825AE4779Q33825703-415EB521-5E47-4124-8B2B-F7D7DB48496DQ33855416-E5FA69E1-BBC6-4C3C-B459-4DFF541AEF39Q34182459-49263F0F-6BD5-4FD6-8E72-3C1B464D8EEEQ34604639-65F542B4-F931-4C1B-BD3E-9FD504D0AC75Q35025062-66845B18-830E-4734-9C0B-40BCD6B5B1B7Q35039830-1CCF98D1-57E3-4A14-A326-226EBC9B976FQ35188247-C10C52A2-5F01-4691-99AF-5A20CF836AFAQ35623688-F79BE472-8DF9-4D0E-A180-22AB0F65B2FAQ35884800-7F58A7B5-E8AE-4B8D-9D1B-E7C8FF2BED8BQ35960675-216C3DAD-7045-4FA4-847C-556238A17061Q36405118-0A3FB7D9-F340-4C0D-8D3F-CEB4A3D2E8E4Q37309962-4D78CFD9-07D5-4B56-8784-80ED386FE8BAQ37351388-EE296EC3-5831-4C73-A8D7-E7C1603F43E1Q37355665-3A3571E6-3C58-43C0-9F4E-64F7D02FCA27Q37357672-27F635C8-AF96-4FAD-9553-3029ADBB8FC2Q37496988-FCCAA0E4-ECD4-4AE9-9A3D-7A5210D09753Q38646429-557CE3C5-D422-4530-8819-4127B27DDEC7Q43151863-394996F3-3386-4145-81EB-96F32164044CQ47136512-CB4D6B5A-2F3C-4F6E-AC4F-F58091690ECFQ57418519-EB4C4561-E843-4B44-B684-CDB0397F83B4
P2860
The impact of HIV antiviral therapy on human papillomavirus (HPV) infections and HPV-related diseases.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The impact of HIV antiviral th ...... ions and HPV-related diseases.
@ast
The impact of HIV antiviral th ...... ions and HPV-related diseases.
@en
type
label
The impact of HIV antiviral th ...... ions and HPV-related diseases.
@ast
The impact of HIV antiviral th ...... ions and HPV-related diseases.
@en
prefLabel
The impact of HIV antiviral th ...... ions and HPV-related diseases.
@ast
The impact of HIV antiviral th ...... ions and HPV-related diseases.
@en
P2093
P1433
P1476
The impact of HIV antiviral th ...... tions and HPV-related diseases
@en
P2093
Isabelle Heard
Joel M Palefsky
Michel D Kazatchkine
P577
2004-02-01T00:00:00Z